Emma Chan

Title: Emma Chan - Innovator in T Cell Preparation

Introduction

Emma Chan is a prominent inventor based in London, GB. She has made significant contributions to the field of biotechnology, particularly in the preparation of T cells for therapeutic applications. Her innovative work has the potential to advance treatments for various diseases.

Latest Patents

Emma Chan holds a patent for a method of preparing T cells with increased activity. The patent describes a process that involves providing a starting population of cells, depleting those that express a target antigen, and introducing a nucleic acid sequence encoding a chimeric antigen receptor (CAR) or a transgenic T-cell receptor (TCR). This invention also encompasses genetically modified cells and pharmaceutical compositions aimed at treating and preventing diseases. She has 1 patent to her name.

Career Highlights

Emma Chan is currently associated with Autolus Limited, where she continues to work on innovative solutions in cell therapy. Her expertise in genetic modification of T cells positions her as a key player in the biotechnology sector.

Collaborations

Emma collaborates with notable colleagues such as Martin Pulé and Carlotta Petticone, contributing to a dynamic research environment focused on advancing cell therapy technologies.

Conclusion

Emma Chan's work in the preparation of T cells represents a significant advancement in biotechnology. Her innovative methods and collaborations are paving the way for new therapeutic options in the treatment of diseases.